Federal Court Determines That Patient Has Liberty Interest in Receiving Investigational Drug

On May 17, 2016, a federal judge, citing arbitrary and capricious decisionmaking by FDA and notice-based due process concerns, granted a plaintiff’s emergency motion for a temporary restraining order against FDA, thereby preventing FDA from putting a clinical drug trial on hold with respect to the plaintiff, Eugene “Neil” Fachon.

Tweet Like LinkedIn LinkedIn Google Plus